Drug-induced or toxic liver disease with chronic fatty liver disease (Q43593): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 10:40, 13 August 2026
This is a chronic drug-induced steatosis characterised by relatively large triglyceride globules, which effectively fill the hepatocyte, displace the nucleus and other intracellular constituents to the periphery. Some patients show steatohepatitis, steatosis with focal necrosis and inflammatory cell infiltrate, leading to the development of cirrhosis.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | DB95.30 |
||
| English | Drug-induced or toxic liver disease with chronic fatty liver disease |
This is a chronic drug-induced steatosis characterised by relatively large triglyceride globules, which effectively fill the hepatocyte, displace the nucleus and other intracellular constituents to the periphery. Some patients show steatohepatitis, steatosis with focal necrosis and inflammatory cell infiltrate, leading to the development of cirrhosis. |
Statements
CID11:DB95.30
0 references
dki-india-DB95.30
0 references
Concluído
0 references
13 August 2026
0 references
